Publications by authors named "Anthony Cleare"

Claim this Profile
C
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trial.
Agata Łaszewska, Timea Helter, Ashley Baldwin, Anthony J Cleare, Philip J Cowen

Lancet Reg Health Eur· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium Point-of-Care Testing to Improve Adherence to Monitoring Guidelines and Quality of Maintenance Therapy: Protocol for a Randomised Feasibility Trial.
Jess Kerr-Gaffney, Priyanka Prakash, Victoria C Wing, Allan H Young, Oisín N Kavanagh, Anthony J Cleare

Pharmaceuticals (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in health-related quality of life with esketamine nasal spray versus quetiapine extended release.
Andreas Reif, Bernhard T Baune, Jozefien Buyze, Anthony J Cleare, Shaun Johnson

Eur Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Sleep Parameters Predict Upcoming Mood Episodes in Bipolar Disorder?
Andrea Ulrichsen, Esther Mühlbauer, Lisa-Marie Hartnagel, Emanuel Severus, Anthony Cleare

Bipolar Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.
Michael Browning, Philip J Cowen, Ushma Galal, Ashley Baldwin, Anthony J Cleare

Lancet Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis" [Journal of affective disorders, 322 (2023), 194-204].
Kwonmok Ko, Emma I Kopra, Anthony J Cleare, James J Rucker

J Affect Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.
Nadav Liam Modlin, Maples-Keller Jessica L, Maria Sarang, Lucie Siebenaler, Carolina Maggio, Anthony Cleare

Psychiatry Clin Psychopharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.
Nadav Liam Modlin, Victoria Williamson, Carolina Maggio, Joanne Stubley, Namik Kirlic, Anthony Cleare

Ther Adv Psychopharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the mechanisms of action of probiotics in depression: Results from a randomized controlled pilot trial.
Viktoriya L Nikolova, Anthony J Cleare, Allan H Young, James M Stone

J Affect Disord· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial.
Jess Kerr-Gaffney, Zohra Zenasni, Kimberley Goldsmith, Nahel Yaziji, Huajie Jin, Anthony J Cleare

Health Technol Assess· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.
Eduard Vieta, Nahida Ahmed, Celso Arango, Anthony J Cleare, Koen Demyttenaere

Eur Neuropsychopharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK.
Anthony J Cleare, Jess Kerr-Gaffney, Kimberley Goldsmith, Zohra Zenasni, Nahel Yaziji

Lancet Psychiatry· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do sleep variables predict mood in bipolar disorder: A systematic review.
Andrea Ulrichsen, Anna Tröger, Sameer Jauhar, Emanuel Severus, Michael Bauer, Anthony Cleare

J Affect Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot cluster-controlled trial of interventions to improve detection of depression in primary healthcare in Ethiopia.
Abebaw Fekadu, Barkot Milkias, Rahel Birhane, Bethlehem Tekola, Mahlet Yared, Anthony J Cleare

BMC Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.
Nadav Liam Modlin, Tyler McPhee, Nira Zazon, Maria Sarang, Rebecca Hignett, Anthony Cleare

Psychedelic Med (New Rochelle)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature.
Gianmarco Ingrosso, Anthony J Cleare, Mario F Juruena

J Psychopharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of outcome following psychological therapy for depression and anxiety in an urban primary care service: a naturalistic Bayesian prediction modeling approach.
John Hodsoll, Rebecca Strawbridge, Sinead King, Rachael W Taylor, Gerome Breen, Anthony J Cleare

Psychol Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.
Ronit Kishon, Nadav Liam Modlin, Yael M Cycowicz, Hania Mourtada, Tayler Wilson, Anthony Cleare

Npj Ment Health Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis". [J. Affect. Disord., 322 (2023), 194-204].
Kwonmok Ko, Emma I Kopra, Anthony J Cleare, James J Rucker

J Affect Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing interventions to improve detection of depression in primary healthcare settings in rural Ethiopia.
Mekdes Demissie, Rahel Birhane, Charlotte Hanlon, Tigist Eshetu, Girmay Medhin, Anthony J Cleare

BJPsych Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.
Kwonmok Ko, Ben Carter, Anthony J Cleare, James J Rucker

Neuropsychiatr Dis Treat· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Functional Impairment in Bipolar Disorder: Results From 13 Cohorts From Seven Countries by the Global Bipolar Cohort Collaborative.
Katherine E Burdick, Caitlin E Millett, Anastasia K Yocum, Cara M Altimus, Ole A Andreassen, Anthony J Cleare

Focus (Am Psychiatr Publ)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression.
Sameer Jauhar, Danilo Arnone, David S Baldwin, Michael Bloomfield, Michael Browning, Anthony J Cleare

Mol Psychiatry· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis